Search

Search Results

• 

  Perivascular fibrosis and IgG4-related disease: a case report

  S. Monti, G. Crepaldi, A. Peri, A. Pietrabissa, P. Morbini, F. Bobbio-Pallavicini, C. Montecucco, R. Caporali

  245-248

  06-11-2014

  Published: 6 November 2014

  1849

  PDF: 1009
• 

  Lifestyle and dietary habits of patients with gout followed in rheumatology settings

  M. Manara, G. Carrara, C. A. Scirè, M. A. Cimmino, M. Govoni, C. Montecucco, M. Matucci-Cerinic, G. Minisola, the KING study group

  138-148

  23-05-2016

  Published: 23 May 2016

  2723

  PDF: 3118
• 

  B cell autoimmunity and bone damage in rheumatoid arthritis

  S. Bugatti, L. Bogliolo, C. Montecucco, A. Manzo

  117-125

  16-12-2016

  Published: 16 December 2016

  2928

  PDF: 1855
• 

  Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis

  M. Todoerti, W. Maglione, E. Bernero, A. Bortoluzzi, M. Colaci, E. Galuppi, S. Paolino, R. Talarico, M. Cutolo, C. Ferri, F. Trotta, S. Bombardieri, C.M. Montecucco, L. Sinigaglia

  207-218

  18-12-2013

  Published: 18 December 2013

  4093

  PDF: 2529
• 

  Diffuse alveolar hemorrhage as a manifestation of Behçet disease

  V. Grosso, E. Boveri, L. Bogliolo, C. Montecucco, R. Caporali

  138-141

  24-07-2013

  Published: 24 July 2013

  2521

  PDF: 838

• Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the “3E initiative”

  F. De Leonardis, S. Aliverini, E. Bonacci, A.M. Buono, S. Bombardieri, G.F. Ferraccioli, C. Montecucco, L. Sinigaglia, F. Trotta, G. Valentini

  34-45

  Published:

  1946

  PDF: 2202

• Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine

  L. Cavagna, P. Rossi, L. Bogliolo, E. Antoniazzi, C. Gelmi, R. Caporali, C. Montecucco

  226-231

  Published:

  2244
• 

  Histopathology of the synovial tissue: perspectives for biomarker development in chronic inflammatory arthritides

  A. Manzo, S. Bugatti, R. Caporali, C. Montecucco

  121-132

  03-10-2018

  Published: 3 October 2018

  1623

  PDF: 1132

• Italian Society of Rheumatology (SIR) recommendations for performing arthrocentesis

  L. Punzi, M.A. Cimmino, L. Frizziero, V. Gerloni, W. Grassi, V. Modena, C. Montecucco, R. Ramonda, F. Schiavon, A. Spadaro, F. Trotta

  227-234

  Published:

  2173

  PDF: 2143

• Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2)

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, V. Coletta, C. Montecucco

  12-33

  Published:

  1449

  PDF: 1162

• Role of chemokines in the pathogenesis of rheumatoid synovitis

  F. Ingegnoli, A. Manzo, F. Fantini, R. Caporali, C. Montecucco, N. Pipitone, C. Pitzalis

  12-18

  Published:

  706

  PDF: 777

• TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

  I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

  275-282

  Published:

  964

  PDF: 897

• Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco

  197-211

  Published:

  1131

  PDF: 867

• Compressive cervical myelopathy due to massive periodontoid calcium pyrophosphate crystal deposition

  F. Bobbio-Pallavicini, O. Epis, L. Cavagna, R. Caporali, C. Montecucco

  312-315

  Published:

  822

  PDF: 1822

• Approved indications and other possible utilizations of anti-TNFa biologic drugs

  W. Grassi, C. Montecucco

  30-33

  Published:

  1078

  PDF: 843

• MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

  P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

  132-139

  Published:

  1807

  PDF: 1103

• Milwaukee shoulder syndrome (apatite associated destructive arthritis): therapeutic aspects

  O. Epis, E. Viola, E. Bruschi, F. Benazzo, C. Montecucco

  69-77

  Published:

  1918

  PDF: 4292

• Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

  P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

  290-295

  Published:

  1987

  PDF: 1035

• Outcome predictors in rheumatoid arthritis

  C. Montecucco

  21-27

  Published:

  855

  PDF: 863
• 

  Denosumab for the treatment of HIV-associated osteoporosis with fractures in a premenopausal woman

  E. Marasco, M. Mussa, F. Motta, F. Bobbio-Pallavicini, R. Maserati, C. Montecucco, L. Bogliolo

  54-58

  19-04-2021

  Published: 19 April 2021

  5493

  PDF: 794

• The new edition of Reumatismo

  L. Punzi, C. Montecucco

  161-162

  Published:

  1250

  PDF: 579

• Plasma procalcitonin in rheumatic diseases

  C.A. Scirè, R. Caporali, C. Perotti, C. Montecucco

  113-118

  Published:

  1463

  PDF: 5250
• 

  Multidisciplinary model for hospital-territory integrated management of patient with bone fragility: primary and secondary prevention of fractures according to severity and complexity

  C. Caffetti, L. Bogliolo, G. Giuffrè, A. Sozzi, L. Degli Esposti, E. Bellis, C. Montecucco, F. Reitano, A. Triarico, S. Silva, M. Bejor, A. Muzzi, P. Mirabile, N. Ramaioli, M. Brait

  75-85

  23-07-2020

  Published: 23 July 2020

  977

  PDF: 687

• The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet

  P. Sfriso, F. Salaffi, S. Bombardieri, B. Canesi, C.M. Montecucco, S. Todesco

  77-84

  Published:

  1725

  PDF: 798